SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jun. 11, 2018--
Prime Therapeutics, Inc. (Nasdaq: FPRX), a biotechnology company
discovering and developing innovative immuno-oncology protein
therapeutics, today announced that Aron Knickerbocker, Chief Executive
Officer, will present at the Goldman Sachs 39th Annual Global Healthcare
Conference, June 14, 2018, at 8:00 am PT.
The presentation will be webcast and may be accessed at the “Events &
Presentations” section of the Company’s website at http://investor.fiveprime.com/events.cfm.
Five Prime will maintain an archived replay of the webcast on its
website for 30 days after the conference.
About Five Prime
Five Prime Therapeutics, Inc. discovers and develops innovative
therapeutics to improve the lives of patients with serious diseases.
Five Prime's comprehensive discovery platform, which encompasses
virtually every medically relevant extracellular protein, positions it
to explore pathways in cancer, inflammation and their intersection in
immuno-oncology, an area with significant therapeutic potential and the
focus of the company's R&D activities. Five Prime has entered into
strategic collaborations with leading global pharmaceutical companies
and has promising product candidates in clinical and late preclinical
development. For more information, please visit www.fiveprime.com
or follow us on LinkedIn,
View source version on businesswire.com: https://www.businesswire.com/news/home/20180611005946/en/
Source: Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Heather Rowe, 415-365-5737
Director, Investor Relations and Corporate Communications